Secord, A. A., Teoh, D. K., Barry, W. T., Yu, M., Broadwater, G., Havrilesky, L. J., . . . Wenham, R. M. (2012). A phase I trial of dasatinib, a Src-family kinase Inhibitor, in combination with paclitaxel and carboplatin in patients with advanced or recurrent ovarian cancer.
Citação norma ChicagoSecord, Angeles Alvarez, et al. A Phase I Trial of Dasatinib, a Src-family Kinase Inhibitor, in Combination With Paclitaxel and Carboplatin in Patients With Advanced or Recurrent Ovarian Cancer. 2012.
Citação norma MLASecord, Angeles Alvarez, et al. A Phase I Trial of Dasatinib, a Src-family Kinase Inhibitor, in Combination With Paclitaxel and Carboplatin in Patients With Advanced or Recurrent Ovarian Cancer. 2012.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.